Study Stopped
Study suspended pending further funding
Evaluation of the Role of Vibrational Spectroscopy in the Assessment of Vulval Disease
Vulval VS
1 other identifier
observational
200
1 country
1
Brief Summary
Can vibrational spectroscopy be used to accurately assess vulval skin conditions? Vulval skin disorders are common and the diagnosis of these conditions can be difficult. Reliable discrimination between benign vulval skin conditions, precancerous conditions or vulval cancer often requires tissue biopsies. In addition the monitoring of patients with vulval disease at risk cancerous change is currently limited to visual assessment often supplemented by multiple invasive tissue biopsies. There are currently no established non invasive tests available for the diagnosis of vulval skin diseases. The vibrational spectroscopic techniques of Raman spectroscopy and Fourier transform infrared spectroscopy are non invasive diagnostic tools that use the interaction of light within tissues to identify the chemical composition of different tissues. The use of these tools may reduce the need for invasive biopsies to diagnose and monitor women with vulval skin disease. The aim of this project is to explore the use of vibrational spectroscopic techniques in the diagnosis of vulval skin disease. This will be achieved by performing vibrational spectroscopy on samples of tissue previously taken from women with vulval skin disease treated at Gloucestershire Hospitals NHS Foundation Trust. The results of the spectroscopy will be compared with the routine tests and the accuracy of spectroscopy determined.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 21, 2014
CompletedFirst Posted
Study publicly available on registry
August 22, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2018
CompletedAugust 4, 2017
August 1, 2017
4 years
August 21, 2014
August 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Diagnostic performance of vibrational spectroscopic techniques for differentiating key vulval tissue types
* Normal vulval skin * Lichen Sclerosus * High grade dysplasia - Usual type ('Vulval Intraepithelial Neoplasia 2-3') * High grade dysplasia - Differentiated type ('Vulval Intraepithelial Neoplasia 2-3') * Squamous cell carcinoma
2 years
Diagnostic performance of vibrational spectroscopic techniques for differentiating between normal and diseased lymph nodes in vulval carcinoma.
Diagnostic performance of vibrational spectroscopic techniques for differentiating between normal and diseased lymph nodes in vulval carcinoma.
2 years
Secondary Outcomes (1)
Diagnostic performance of vibrational spectroscopic techniques for differentiating other vulval tissue types
2 years
Study Arms (1)
Vulval Disease
Patients who have undergone vulval skin biopsy or surgery for a vulval condition within Gloucestershire Hospitals NHS Foundation Trust.
Eligibility Criteria
Patients who have undergone vulval skin biopsy or surgery for a vulval condition within Gloucestershire Hospitals NHS Foundation Trust.
You may qualify if:
- Vulval skin tissue stored after routine histopathological analysis from women treated or investigated for a vulval skin condition.
- Inguinofemoral lymph nodes stored after routine histopathological analysis from women treated for vulval cancer.
You may not qualify if:
- Tissue specimens inadequate for analysis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gloucestershire Hospitals NHS Foundation Trust
Gloucester, Gloucestershire, GL1 3NN, United Kingdom
Biospecimen
Histological sections of vulval and lymph node tissue.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Research Fellow
Study Record Dates
First Submitted
August 21, 2014
First Posted
August 22, 2014
Study Start
August 1, 2014
Primary Completion
August 1, 2018
Study Completion
August 1, 2018
Last Updated
August 4, 2017
Record last verified: 2017-08